 | • レポートコード：GIR-107A12652 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、組換え細胞培養サプリメントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。組換え細胞培養サプリメントの種類別市場規模（組換えアルブミン、組換えインスリン、組換え上皮成長因子、組換えトランスフェリン、その他）、用途別市場規模（幹細胞・再生医療、バイオプロダクション、学術・研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・組換え細胞培養サプリメントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BBI Solutions、Corning、Evercyte、Gemini Bio-Products、Lonza Group、Merck、Novozymes、Repligen、Thermo Fisher Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：組換えアルブミン、組換えインスリン、組換え上皮成長因子、組換えトランスフェリン、その他 ・用途別分析2016年-2026年：幹細胞・再生医療、バイオプロダクション、学術・研究 ・組換え細胞培養サプリメントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・組換え細胞培養サプリメントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・組換え細胞培養サプリメントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・組換え細胞培養サプリメントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・組換え細胞培養サプリメントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Cell Culture Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Cell Culture Supplements size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Recombinant Cell Culture Supplements market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Cell Culture Supplements market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Recombinant Albumin
Recombinant Insulin
Recombinant Epidermal Growth Factor
Recombinant Transferrin
Others
Market segment by Application, can be divided into
Stem Cell and Regenerative Medicine
BioProduction
Academic and Research Application
Market segment by players, this report covers
BBI Solutions
Corning
Evercyte
Gemini Bio-Products
Lonza Group
Merck
Novozymes
Repligen
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Recombinant Cell Culture Supplements
1.2 Classification of Recombinant Cell Culture Supplements by Type
1.2.1 Overview: Global Recombinant Cell Culture Supplements Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Recombinant Cell Culture Supplements Revenue Market Share by Type in 2020
1.2.3 Recombinant Albumin
1.2.4 Recombinant Insulin
1.2.5 Recombinant Epidermal Growth Factor
1.2.6 Recombinant Transferrin
1.2.7 Others
1.3 Global Recombinant Cell Culture Supplements Market by Application
1.3.1 Overview: Global Recombinant Cell Culture Supplements Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Stem Cell and Regenerative Medicine
1.3.3 BioProduction
1.3.4 Academic and Research Application
1.4 Global Recombinant Cell Culture Supplements Market Size & Forecast
1.5 Global Recombinant Cell Culture Supplements Market Size and Forecast by Region
1.5.1 Global Recombinant Cell Culture Supplements Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Recombinant Cell Culture Supplements Market Size by Region, (2016-2021)
1.5.3 North America Recombinant Cell Culture Supplements Market Size and Prospect (2016-2026)
1.5.4 Europe Recombinant Cell Culture Supplements Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Recombinant Cell Culture Supplements Market Size and Prospect (2016-2026)
1.5.6 South America Recombinant Cell Culture Supplements Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Recombinant Cell Culture Supplements Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Cell Culture Supplements Market Drivers
1.6.2 Recombinant Cell Culture Supplements Market Restraints
1.6.3 Recombinant Cell Culture Supplements Trends Analysis
2 Company Profiles
2.1 BBI Solutions
2.1.1 BBI Solutions Details
2.1.2 BBI Solutions Major Business
2.1.3 BBI Solutions Recombinant Cell Culture Supplements Product and Solutions
2.1.4 BBI Solutions Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 BBI Solutions Recent Developments and Future Plans
2.2 Corning
2.2.1 Corning Details
2.2.2 Corning Major Business
2.2.3 Corning Recombinant Cell Culture Supplements Product and Solutions
2.2.4 Corning Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Corning Recent Developments and Future Plans
2.3 Evercyte
2.3.1 Evercyte Details
2.3.2 Evercyte Major Business
2.3.3 Evercyte Recombinant Cell Culture Supplements Product and Solutions
2.3.4 Evercyte Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Evercyte Recent Developments and Future Plans
2.4 Gemini Bio-Products
2.4.1 Gemini Bio-Products Details
2.4.2 Gemini Bio-Products Major Business
2.4.3 Gemini Bio-Products Recombinant Cell Culture Supplements Product and Solutions
2.4.4 Gemini Bio-Products Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Gemini Bio-Products Recent Developments and Future Plans
2.5 Lonza Group
2.5.1 Lonza Group Details
2.5.2 Lonza Group Major Business
2.5.3 Lonza Group Recombinant Cell Culture Supplements Product and Solutions
2.5.4 Lonza Group Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Lonza Group Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Recombinant Cell Culture Supplements Product and Solutions
2.6.4 Merck Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck Recent Developments and Future Plans
2.7 Novozymes
2.7.1 Novozymes Details
2.7.2 Novozymes Major Business
2.7.3 Novozymes Recombinant Cell Culture Supplements Product and Solutions
2.7.4 Novozymes Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novozymes Recent Developments and Future Plans
2.8 Repligen
2.8.1 Repligen Details
2.8.2 Repligen Major Business
2.8.3 Repligen Recombinant Cell Culture Supplements Product and Solutions
2.8.4 Repligen Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Repligen Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific Recombinant Cell Culture Supplements Product and Solutions
2.9.4 Thermo Fisher Scientific Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant Cell Culture Supplements Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Recombinant Cell Culture Supplements Players Market Share
3.2.2 Top 10 Recombinant Cell Culture Supplements Players Market Share
3.2.3 Market Competition Trend
3.3 Recombinant Cell Culture Supplements Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Recombinant Cell Culture Supplements Revenue and Market Share by Type (2016-2021)
4.2 Global Recombinant Cell Culture Supplements Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Recombinant Cell Culture Supplements Revenue Market Share by Application (2016-2021)
5.2 Recombinant Cell Culture Supplements Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Recombinant Cell Culture Supplements Revenue by Type (2016-2026)
6.2 North America Recombinant Cell Culture Supplements Revenue by Application (2016-2026)
6.3 North America Recombinant Cell Culture Supplements Market Size by Country
6.3.1 North America Recombinant Cell Culture Supplements Revenue by Country (2016-2026)
6.3.2 United States Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
6.3.3 Canada Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
6.3.4 Mexico Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Recombinant Cell Culture Supplements Revenue by Type (2016-2026)
7.2 Europe Recombinant Cell Culture Supplements Revenue by Application (2016-2026)
7.3 Europe Recombinant Cell Culture Supplements Market Size by Country
7.3.1 Europe Recombinant Cell Culture Supplements Revenue by Country (2016-2026)
7.3.2 Germany Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
7.3.3 France Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
7.3.5 Russia Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
7.3.6 Italy Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Recombinant Cell Culture Supplements Revenue by Type (2016-2026)
8.2 Asia-Pacific Recombinant Cell Culture Supplements Revenue by Application (2016-2026)
8.3 Asia-Pacific Recombinant Cell Culture Supplements Market Size by Region
8.3.1 Asia-Pacific Recombinant Cell Culture Supplements Revenue by Region (2016-2026)
8.3.2 China Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8.3.3 Japan Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8.3.4 South Korea Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8.3.5 India Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
8.3.7 Australia Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Recombinant Cell Culture Supplements Revenue by Type (2016-2026)
9.2 South America Recombinant Cell Culture Supplements Revenue by Application (2016-2026)
9.3 South America Recombinant Cell Culture Supplements Market Size by Country
9.3.1 South America Recombinant Cell Culture Supplements Revenue by Country (2016-2026)
9.3.2 Brazil Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
9.3.3 Argentina Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Recombinant Cell Culture Supplements Revenue by Type (2016-2026)
10.2 Middle East & Africa Recombinant Cell Culture Supplements Revenue by Application (2016-2026)
10.3 Middle East & Africa Recombinant Cell Culture Supplements Market Size by Country
10.3.1 Middle East & Africa Recombinant Cell Culture Supplements Revenue by Country (2016-2026)
10.3.2 Turkey Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
10.3.4 UAE Recombinant Cell Culture Supplements Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Recombinant Cell Culture Supplements Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Recombinant Cell Culture Supplements Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Recombinant Cell Culture Supplements Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Recombinant Cell Culture Supplements Revenue (USD Million) by Region (2016-2021)
Table 5. Global Recombinant Cell Culture Supplements Revenue Market Share by Region (2021-2026)
Table 6. BBI Solutions Corporate Information, Head Office, and Major Competitors
Table 7. BBI Solutions Major Business
Table 8. BBI Solutions Recombinant Cell Culture Supplements Product and Solutions
Table 9. BBI Solutions Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Corning Corporate Information, Head Office, and Major Competitors
Table 11. Corning Major Business
Table 12. Corning Recombinant Cell Culture Supplements Product and Solutions
Table 13. Corning Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Evercyte Corporate Information, Head Office, and Major Competitors
Table 15. Evercyte Major Business
Table 16. Evercyte Recombinant Cell Culture Supplements Product and Solutions
Table 17. Evercyte Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Gemini Bio-Products Corporate Information, Head Office, and Major Competitors
Table 19. Gemini Bio-Products Major Business
Table 20. Gemini Bio-Products Recombinant Cell Culture Supplements Product and Solutions
Table 21. Gemini Bio-Products Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Lonza Group Corporate Information, Head Office, and Major Competitors
Table 23. Lonza Group Major Business
Table 24. Lonza Group Recombinant Cell Culture Supplements Product and Solutions
Table 25. Lonza Group Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck Recombinant Cell Culture Supplements Product and Solutions
Table 29. Merck Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novozymes Corporate Information, Head Office, and Major Competitors
Table 31. Novozymes Major Business
Table 32. Novozymes Recombinant Cell Culture Supplements Product and Solutions
Table 33. Novozymes Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Repligen Corporate Information, Head Office, and Major Competitors
Table 35. Repligen Major Business
Table 36. Repligen Recombinant Cell Culture Supplements Product and Solutions
Table 37. Repligen Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 39. Thermo Fisher Scientific Major Business
Table 40. Thermo Fisher Scientific Recombinant Cell Culture Supplements Product and Solutions
Table 41. Thermo Fisher Scientific Recombinant Cell Culture Supplements Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Recombinant Cell Culture Supplements Revenue (USD Million) by Players (2019-2021)
Table 43. Global Recombinant Cell Culture Supplements Revenue Share by Players (2019-2021)
Table 44. Breakdown of Recombinant Cell Culture Supplements by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Recombinant Cell Culture Supplements Players Head Office, Products and Services Provided
Table 46. Recombinant Cell Culture Supplements Mergers & Acquisitions in the Past Five Years
Table 47. Recombinant Cell Culture Supplements New Entrants and Expansion Plans
Table 48. Global Recombinant Cell Culture Supplements Revenue (USD Million) by Type (2016-2021)
Table 49. Global Recombinant Cell Culture Supplements Revenue Share by Type (2016-2021)
Table 50. Global Recombinant Cell Culture Supplements Revenue Forecast by Type (2021-2026)
Table 51. Global Recombinant Cell Culture Supplements Revenue by Application (2016-2021)
Table 52. Global Recombinant Cell Culture Supplements Revenue Forecast by Application (2021-2026)
Table 53. North America Recombinant Cell Culture Supplements Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Recombinant Cell Culture Supplements Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Recombinant Cell Culture Supplements Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Recombinant Cell Culture Supplements Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Recombinant Cell Culture Supplements Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Recombinant Cell Culture Supplements Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Recombinant Cell Culture Supplements Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Recombinant Cell Culture Supplements Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Recombinant Cell Culture Supplements Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Recombinant Cell Culture Supplements Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Recombinant Cell Culture Supplements Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Recombinant Cell Culture Supplements Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Recombinant Cell Culture Supplements Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Recombinant Cell Culture Supplements Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Recombinant Cell Culture Supplements Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Recombinant Cell Culture Supplements Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Recombinant Cell Culture Supplements Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Recombinant Cell Culture Supplements Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Recombinant Cell Culture Supplements Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Recombinant Cell Culture Supplements Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Recombinant Cell Culture Supplements Picture
Figure 2. Global Recombinant Cell Culture Supplements Revenue Market Share by Type in 2020
Figure 3. Recombinant Albumin
Figure 4. Recombinant Insulin
Figure 5. Recombinant Epidermal Growth Factor
Figure 6. Recombinant Transferrin
Figure 7. Others
Figure 8. Recombinant Cell Culture Supplements Revenue Market Share by Application in 2020
Figure 9. Stem Cell and Regenerative Medicine Picture
Figure 10. BioProduction Picture
Figure 11. Academic and Research Application Picture
Figure 12. Global Recombinant Cell Culture Supplements Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Recombinant Cell Culture Supplements Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Recombinant Cell Culture Supplements Revenue Market Share by Region (2016-2026)
Figure 15. Global Recombinant Cell Culture Supplements Revenue Market Share by Region in 2020
Figure 16. North America Recombinant Cell Culture Supplements Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Recombinant Cell Culture Supplements Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Recombinant Cell Culture Supplements Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Recombinant Cell Culture Supplements Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Recombinant Cell Culture Supplements Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Recombinant Cell Culture Supplements Market Drivers
Figure 22. Recombinant Cell Culture Supplements Market Restraints
Figure 23. Recombinant Cell Culture Supplements Market Trends
Figure 24. BBI Solutions Recent Developments and Future Plans
Figure 25. Corning Recent Developments and Future Plans
Figure 26. Evercyte Recent Developments and Future Plans
Figure 27. Gemini Bio-Products Recent Developments and Future Plans
Figure 28. Lonza Group Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Novozymes Recent Developments and Future Plans
Figure 31. Repligen Recent Developments and Future Plans
Figure 32. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 33. Global Recombinant Cell Culture Supplements Revenue Share by Players in 2020
Figure 34. Recombinant Cell Culture Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Recombinant Cell Culture Supplements Revenue Market Share in 2020
Figure 36. Global Top 10 Players Recombinant Cell Culture Supplements Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Recombinant Cell Culture Supplements Revenue Share by Type in 2020
Figure 39. Global Recombinant Cell Culture Supplements Market Share Forecast by Type (2021-2026)
Figure 40. Global Recombinant Cell Culture Supplements Revenue Share by Application in 2020
Figure 41. Global Recombinant Cell Culture Supplements Market Share Forecast by Application (2021-2026)
Figure 42. North America Recombinant Cell Culture Supplements Sales Market Share by Type (2016-2026)
Figure 43. North America Recombinant Cell Culture Supplements Sales Market Share by Application (2016-2026)
Figure 44. North America Recombinant Cell Culture Supplements Revenue Market Share by Country (2016-2026)
Figure 45. United States Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Recombinant Cell Culture Supplements Sales Market Share by Type (2016-2026)
Figure 49. Europe Recombinant Cell Culture Supplements Sales Market Share by Application (2016-2026)
Figure 50. Europe Recombinant Cell Culture Supplements Revenue Market Share by Country (2016-2026)
Figure 51. Germany Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Recombinant Cell Culture Supplements Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Recombinant Cell Culture Supplements Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Recombinant Cell Culture Supplements Revenue Market Share by Region (2016-2026)
Figure 59. China Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Recombinant Cell Culture Supplements Sales Market Share by Type (2016-2026)
Figure 66. South America Recombinant Cell Culture Supplements Sales Market Share by Application (2016-2026)
Figure 67. South America Recombinant Cell Culture Supplements Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Recombinant Cell Culture Supplements Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Recombinant Cell Culture Supplements Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Recombinant Cell Culture Supplements Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Recombinant Cell Culture Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の組換え細胞培養サプリメント市場予測（～2024年） Recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. Scope of the Report: The global Recombinant Cell Culture Supplements market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 202…- 世界の抗血友病因子（組換え）市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のアンチトロンビン（組換え）市場 2021：企業別、地域別、種類・用途別 The Antithrombin (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 組換えトリプシンパウダーの世界市場 2019年版：種類別（チューブ包装、ボトル包装）、用途別（インスリン製造、ワクチン製造、細胞培養、遺伝子治療、その他） Scope of the Report: The worldwide market for Recombinant Trypsin Powder is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Recombinant …
- 組換えタンパク質ワクチンの世界市場 2019年版：種類別（細菌細胞培養、哺乳類細胞培養）、用途別（人間、動物） Scope of the Report: The worldwide market for Recombinant Protein Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Recombinant…